TiGenix
TiGenix was a Belgian biopharmaceutical company focused on developing and commercializing stem cell therapies for inflammatory and autoimmune diseases. The company was acquired by Takeda Pharmaceutical Company in 2018 and now operates as part of the Takeda group.
Brand Identity Data
HQ Country
Belgium
HQ City
Madrid
Founded
2000
EU Headquartered
Yes
EU Manufactured
Yes
Stock Exchange
Private
Repair / Recycling
No
Ethical Certifications
None verified
Verified on July 22, 2026